For example, miR-206 represses the viability and migration and enhances the apoptosis of EPCs from patients with CAD through inhibiting vascular endothelial growth factor (VEGF) expression, which suggests that miR-206 can be a novel biomarker for CAD [16]. The gene discussed is VEGFA; the disease is coronary artery disorder.